| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $76.5M | +21.0% |
| SG&A Expense | $23.5M | +2.7% |
| Operating Income | -$100.0M | -18.3% |
| Interest Expense | $6.6M | +6.4% |
| Income Tax | $0 | — |
| Net Income | -$110.8M | -825.8% |
| EPS (Basic) | -$1.07 | -791.7% |
| EPS (Diluted) | -$1.07 | -791.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $80.4M | -46.3% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $0 | -100.0% |
| Current Assets | $83.3M | -46.0% |
| Total Assets | $128.2M | -37.2% |
| Current Liabilities | $18.4M | -5.8% |
| Total Liabilities | $114.7M | +31.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$73.3M | -3.1% |
| Capital Expenditures | $2.3M | +117.6% |
| Investing Cash Flow | -$173K | -103.6% |
| Financing Cash Flow | $4.5M | +411.7% |
| Free Cash Flow | -$75.6M | -4.7% |
| Stockholders' Equity |
| $13.5M |
| -88.4% |